logo-loader
viewMercia Asset Management PLC

Mercia Asset Management providing much needed capital to the 'under-served' UK regions

 

Mercia Asset Management PLC's (LON:MERC) Dr Mark Payton tells Proactive London's Andrew Scott the original idea behind setting up its funds was that the UK regions are under-served and as a result there are opportunities there with a lack of capital.

''When we first started this up we had £4mln of AUM and when we IPO'd on AIM back in 2014 we had £30mln and it's rapidly grown since then''.

''Historically capital has been centred on London and generally doesn't travel outside the M25 ... our model was really predicated on attracting the money out of London by us deploying it''.

''We have quite a suite of funds ... we manage EIS, venture capital trusts and we manage institutional capital across venture, private equity and debt on a regional and national basis''.

Quick facts: Mercia Asset Management PLC

Price: 21.3 GBX

AIM:MERC
Market: AIM
Market Cap: £93.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ImmuPharma’s partner Avion set to meet FDA in December to discuss Phase 3...

Dr Tim Franklin, Chief Operating Officer of ImmuPharma PLC (LON:IMM) joins Proactive London's Katie Pilbeam to discuss ImmuPharma's announcement that The US Food & Drug Administration (“FDA”) has confirmed 4th December 2020 will be the date for the Type ‘A’ Meeting Request, with Avion...

1 hour, 12 minutes ago

2 min read